LONG-TERM TOLERABILITY OF ULTRAHIGH DOSES OF ANGIOTENSIN II RECEPTOR BLOCKERS (ARBS) IN PATIENTS WITH STAGE 3-4 CHRONIC KIDNEY DISEASE (CKD) | Publicación